As Incyte strives to push its topical JAK inhibitor Opzelura into additional dermatology indications, the company’s latest ...

12 According to the National Eczema Society, children of color are ... Dennie-Morgan lines, and prurigo nodules in comparison to patients with lighter skin tones. 8,12 While the presence of ...

Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent ...

Atopic dermatitis, characterised by persistent itch and recurrent skin lesions, affects up to 1.6 million people in the UK, while prurigo nodularis, which causes intense itch and thick skin nodules, ...

Given the late-breaking data on topical ruxolitinib's effectiveness in prurigo nodularis and its rapid itch relief, how do you foresee this impacting treatment paradigms for chronic pruritic ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

ORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of ...

Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

Twice-daily application of ruxolitinib cream demonstrated an ability to reduce itching and blistering in prurigo nodularis, a ...

Co-moderator Joel Gelfand, MD, of the University of Pennsylvania in Philadelphia, asked whether the medication is "getting where it needs to be" in patients with thick prurigo nodules. Would ...